GeneT researchers present their work at ESGCT 2024

25 october, 2024≈ 6 min read

GeneT researchers presented their scientific work at the European Society of Gene and Cell Therapy Congress, which took place from 22 to 25 October 2024 at the La Nuvola Congress Centre in Rome.

In a vibrant atmosphere of scientific sharing and discussion, GeneT displayed eight scientific posters on the various areas of knowledge explored by the Gene and Cell Therapy research group at CIBB—Centre for Innovation in Biomedicine and Biotechnology.

Find out about the themes of the posters and their presenters:

Poster Title Presenter Category
P0154: Hacking Biology: Optimizing AAV-Based Gene Delivery for Enhanced Region-Specific Brain Targeting Guilherme Gabriel AAV & non integrative vectors
P0279: Mesenchymal Stromal Cell potential to restore autophagy and mitochondria health in Machado-Joseph disease Maria Barros CNS & sensory diseases
P0330: Intra-cisterna magna administration of allele-specific AAV-based therapy alleviates neuropathology and motor deficits in Spinocerebellar Ataxia Type 3 Rui Nobre CNS & sensory diseases
P0367: Characterization and therapeutic potency evaluation of SCA3/MJD iPSC-derived neuroepithelial stem cells silenced for mutant ATXN3 Liliana Mendonça Disease models, IPS cells & organoids
P0920: Maximizing Yield and Functionality in saRNA Production: A Comparative Study of Commercial Kits and In Vitro Transcription Conditions Bruno Marques Non viral vectors/Nanotechnology/RNA therapeutics
P0924: Optimizing in vitro transcription methods for enhanced mRNA-based therapeutics Sara Lopes Non viral vectors/Nanotechnology/RNA therapeutics
P0926: Comparative Analysis of Transfection Kits for Linear, Self-Amplifying, and Circular RNA Cristiana Paulo Non viral vectors/Nanotechnology/RNA therapeutics
P0929: A comparative analysis of commercial kits for enhanced circular mRNA production: yield, profile, and in vitro assessment Dina Pereira Non viral vectors/Nanotechnology/RNA therapeutics